pirenzepine has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Excerpt | Relevance | Reference |
---|---|---|
" Pyridostigmine had a higher elimination (2 h-1) than the absorption rate constant (0." | 1.29 | Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine. ( Breyer-Pfaff, U; Eiermann, B; Maier, U; Schumm, F; Sommer, N; Winne, D, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eiermann, B | 1 |
Sommer, N | 1 |
Winne, D | 1 |
Schumm, F | 1 |
Maier, U | 1 |
Breyer-Pfaff, U | 1 |
1 other study available for pirenzepine and Anti-MuSK Myasthenia Gravis
Article | Year |
---|---|
Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine.
Topics: Adolescent; Adult; Aged; Drug Interactions; Female; Glomerular Filtration Rate; Humans; Kidney Glome | 1993 |